Intrathecal dose intensification by CNS status at diagnosis in the treatment of children with acute lymphoblastic leukemia

References

• Winick N, Devidas M, Chen S, et al. Impact of initial CSF findings on outcome among patients with national cancer institute standard- and high-risk B-cell acute lymphoblastic leukemia: a report from the children’s oncology group. J Clin Oncol Off J Am Soc Clin Oncol. 2017;35(22):2527–2534. doi: 10.1200/JCO.2016.71.4774
   PubMed Web of Science ®Google Scholar
• Hill FGH, Richards S, Gibson B, et al. Successful treatment without cranial radiotherapy of children receiving intensified chemotherapy for acute lymphoblastic leukaemia: results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI (ISRC TN 16757172). Br J Haematol. 2004;124(1):33–46. doi: 10.1046/j.1365-2141.2003.04738.x
   PubMed Web of Science ®Google Scholar
• Hudson MM, Neglia JP, Woods WG, et al. Lessons from the past: opportunities to improve childhood cancer survivor care through outcomes investigations of historical therapeutic approaches for pediatric hematological malignancies. Pediatr Blood Cancer. 2012;58(3):334–343. doi: 10.1002/pbc.23385
   PubMed Web of Science ®Google Scholar
• Salzer WL, Devidas M, Carroll WL, et al. Long-term results of the pediatric oncology group studies for childhood acute lymphoblastic leukemia 1984-2001: a report from the children’s oncology group. Leukemia. 2010;24(2):355–370. doi: 10.1038/leu.2009.261
   PubMed Web of Science ®Google Scholar
• Richards S, Pui C-H, Gayon P. Systematic review and meta-analysis of randomized trials of central nervous system directed therapy for childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2013;60(2):185–195. doi: 10.1002/pbc.24228
   PubMed Web of Science ®Google Scholar
• Gajjar A, Harrison PL, Sandlund JT, et al. Traumatic lumbar puncture at diagnosis adversely affects outcome in childhood acute lymphoblastic leukemia. Blood. 2000;96(10):3381–3384.
   PubMed Web of Science ®Google Scholar
• Fryer C, Felimban S, Paltiel C, et al. Acute lymphoblastic leukemia in children: a fifteen year experience at the princess Nourah Oncology Center, Jeddah. Saudi Arabia. Austral - Asian J Cancer. 2006;5(4):199–204.
   Google Scholar
• Jastaniah W, Elimam N, Abdalla K, et al. Does the early intensification of intrathecal therapy improve outcomes in pediatric acute lymphoblastic leukemia patients with CNS2/TLP+ status at diagnosis? Hematol Amst Neth. 2015;20(10):561–566.
   PubMed Web of Science ®Google Scholar
• Mitchell H-R, Lu X, Myers RM, et al. Prospective, longitudinal assessment of quality of life in children from diagnosis to 3 months off treatment for standard risk acute lymphoblastic leukemia: results of children’s Oncology group study AALL0331. Int J Cancer. 2016;138(2):332–339. doi: 10.1002/ijc.29708
   PubMed Web of Science ®Google Scholar
• Larsen EC, Devidas M, Chen S, et al. Dexamethasone and high-dose methotrexate improve outcome for children and young adults with high-risk B-acute lymphoblastic leukemia: a report from children’s oncology group study AALL0232. J Clin Oncol Off J Am Soc Clin Oncol. 2016;34(20):2380–2388. doi: 10.1200/JCO.2015.62.4544
   PubMed Web of Science ®Google Scholar
• Smith M, Arthur D, Camitta B, et al. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol Off J Am Soc Clin Oncol. 1996;14(1):18–24. doi: 10.1200/JCO.1996.14.1.18
   PubMed Web of Science ®Google Scholar
• The Lancet. Steinherz/Bleyer algorithm method of evaluating traumatic lumbar puncture. [Oct 2014]. Available from: http://www.thelancet.com/cms/attachment/2025028614/2044736503/mmc1.pdf.
   Google Scholar
• Matloub Y, Bostrom BC, Hunger SP, et al. Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the children’s oncology group. Blood. 2011;118(2):243–251. doi: 10.1182/blood-2010-12-322909
   PubMed Web of Science ®Google Scholar
• Seibel NL, Steinherz PG, Sather HN, et al. Early post-induction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the children’s oncology group. Blood. 2008;111(5):2548–2555. doi: 10.1182/blood-2007-02-070342
   PubMed Web of Science ®Google Scholar
• Winter SS, Devidas M, Chen S, et al. Capizzi-style methotrexate with pegasparagase (C-MTX) is superior to high-dose methotrexate (HDMTX) in T-lineage acute lymphoblastic leukemia (T-ALL): results from Children's Oncology Group (COG) AALL0434. Blood. 2015;126(23):794.
   Web of Science ®Google Scholar
• Schultz KR, Pullen DJ, Sather HN, et al. Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the pediatric Oncology group (POG) and children’s cancer group (CCG). Blood. 2007;109.
   Google Scholar
• Seif AE, Fisher BT, Li Y, et al. Patient and hospital factors associated with induction mortality in acute lymphoblastic leukemia. Pediatr Blood Cancer. 2014;61(5):846–852. doi: 10.1002/pbc.24855
   PubMed Web of Science ®Google Scholar
• Jastaniah W, Abrar MB, Khattab TM. Improved outcome in pediatric AML due to augmented supportive care. Pediatr Blood Cancer. 2012;59(5):919–921. doi: 10.1002/pbc.24195
   PubMed Web of Science ®Google Scholar
• Moricke A, Reiter A, Zimmermann M, et al. Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. Blood. 2008;111(9):4477–4489. doi: 10.1182/blood-2007-09-112920
   PubMed Web of Science ®Google Scholar
• Pui CH, Mahmoud HH, Rivera GK, et al. Early intensification of intrathecal chemotherapy virtually eliminates central nervous system relapse in children with acute lymphoblastic leukemia. Blood. 1998;92(2):411–415.
   PubMed Web of Science ®Google Scholar
• Pui C-H, Campana D, Pei D, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med. 2009;360(26):2730–2741. doi: 10.1056/NEJMoa0900386
   PubMed Web of Science ®Google Scholar